DRG Team

Managing Director
Michael Schröder

Michael Schröder serves as the Managing Director of DRG Instruments GmbH, overseeing both the strategic direction and day-to-day operations of the company. He is committed to a values-driven leadership approach, emphasizing quality, efficiency, and the sustainable development of employees and processes within a highly regulated industrial environment.
Values & Vision
His leadership philosophy is grounded in accountability, continuous improvement, and collaborative partnership. Michael Schröder is dedicated to positioning DRG Instruments as a high-performing and reliable partner in the international diagnostics sector. Customer focus, operational excellence, and robust supply chains are core pillars of the company's strategic framework.
Brief CV
Michael Schröder is a qualified Biological Laboratory Technician and Master of technical Management (CCI). He also holds a Lean Six Sigma Green Belt certification, specializing in process optimization and efficiency enhancement.
He brings extensive experience as a Managing Director and in pharmaceutical supply chain management. His professional background is characterized by responsibility for complex value chains, managing international supplier relationships, and ensuring quality, compliance, and supply security.

Head of Research and Development
Dr. Matthias Herkert

Dr. Matthias Herkert is Director of Research and Development for DRG Instruments GmbH located in Marburg, Germany.

With approximately 20 years of experience at leading institutions, Dr. Herkert has a strong theoretical and practical knowledge in the fields of biochemistry and neuroscience, as well as ELISA assay development.

In 2008, Dr. Herkert joined DRG as Senior Scientist in the research and development department. He is responsible for development of new ELISA kits. He also oversees collaboration with project partners, including university hospitals and research groups. In addition, Dr. Herkert represents DRG in National and International Congresses.

Since 2012, Dr. Herkert is Director of Research and Development at DRG Instruments GmbH.

Before joining DRG Instruments, Dr. Herkert worked at the MTM Laboratories AG. In this role, he was appointed as the Head of Assay Development for Germany. His focus was primarily on development and early detection of cervical cancer.

Head of QM/QA
Dr. Hero Brahms

Dr. Hero Brahms is the Head of Production for DRG Instruments GmbH.

In 2002, Dr. Brahms joined the DRG Group as a Developer in the German facility. An integral part of the research and development team of DRG Instruments, he was involved in the development and validation of new ELISAs. Along with his work in research and development, he is the Medical Security Manager of DRG Instruments.

Earlier in his career, Dr. Brahms worked in the field of Oligonucleotide synthesis at the Max-Planck-Institute for Experimental Medicine in Göttingen, Germany.

Dr. Brahms performed research as a postdoctoral scientist, both in immunology and molecular biology. His work on the role of posttranslational modifications in autoimmune diseases and cell biology at the Max-Planck-Institute for Biophysical Chemistry was awarded with the RPI/ RNA award for young scientists by the RNA Society, which is dedicated to the study of Ribonucleic Acid.

Head of Production
Mr. René Linke

Project Management DRG:HYBRiD-XL
Mr. Marco Euler

Product Management ELISA / DRG:HYBRiD-XL
Ms. Julia Räder

Product Management Infectious Diseases / Autoimmunity / DxDATA^TM
Ms. Stefanie Lamers

Vice President of Sales Western & Central Europe
Mr. Andrey Krinitsyn

Order Processing Teamlead
Ms. Carolina Angulo Fiedler

Head of Warehouse
Mr. Philipp Wöstheinrich